Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 40 (1) , 33-38
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromesEP Europace, 2017
- Surface Electrocardiogram Screening for Subcutaneous Implantable Cardioverter-Defibrillators in Japanese Patients With and Without Brugada SyndromeCirculation Journal, 2017
- Brugada Syndrome and the Subcutaneous Implantable Cardioverter-DefibrillatorJACC, 2016
- Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complicationsHeart Rhythm, 2016
- Evaluation of the Necessity for Cardioverter-Defibrillator Implantation in Elderly Patients With Brugada SyndromeCirculation: Arrhythmia and Electrophysiology, 2015
- Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD RegistryEuropean Heart Journal, 2014
- Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromesEP Europace, 2013
- Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter DefibrillatorCirculation, 2013
- The Entirely Subcutaneous Implantable Cardioverter-DefibrillatorJACC, 2012
- Risk Stratification in Brugada SyndromeJACC, 2012